Group One Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Group One Trading’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$7.02K	–	8551
2025 Q4	$7.02K	Sell	500 -2,000	-80%	-$28.1K	﹤0.01%	7012
2025 Q3	$35K	Buy	2,500 +500	+25%	+$7.2K	﹤0.01%	6243
2025 Q2	$30.1K	Buy	+2,000	New	+$28.6K	﹤0.01%	5980
2021 Q3	–	Sell	-500	Closed	-$7K	–	8688
2021 Q2	$7K	Buy	+500	New	+$6.99K	﹤0.01%	7664
2016 Q3	–	Sell	-6,500	Closed	-$67K	–	4847
2016 Q2	$67K	Sell	6,500 -80,000	-92%	-$733K	﹤0.01%	3124
2016 Q1	$782K	Buy	86,500 +71,500	+477%	+$639K	0.01%	1357
2015 Q4	$139K	Sell	15,000 -20,000	-57%	-$219K	﹤0.01%	2769
2015 Q3	$447K	Buy	+35,000	New	+$435K	0.01%	1861
2014 Q4	–	Sell	-500	Closed	-$5K	–	5208
2014 Q3	$5K	Hold	500	–	–	﹤0.01%	4728
2014 Q2	$4K	Buy	+500	New	+$4.21K	﹤0.01%	4847
2013 Q4	–	Sell	-13,500	Closed	-$102K	–	5485
2013 Q3	$102K	Buy	+13,500	New	+$98.2K	﹤0.01%	3007

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Group One Trading's RDY Position: Q1 2026 in Review

Group One Trading sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 2,469 shares — an estimated $34.7K sold.

Group One Trading first reported a position in RDY in Q2 2013 and held it in 7 quarters. The position peaked at $380K in Q1 2016. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Group One Trading reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 2,469 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $34.7K.
Group One Trading first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 7 quarters.
Group One Trading's Dr. Reddy's Laboratories position peaked at $380K in Q1 2016.
247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.